Charles Schwab Investment Management Inc. Boosts Stock Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Charles Schwab Investment Management Inc. increased its position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) by 8.0% in the fourth quarter, Holdings Channel.com reports. The fund owned 233,717 shares of the company’s stock after acquiring an additional 17,372 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Ginkgo Bioworks were worth […]
